|
US606909A
(en)
|
|
1898-07-05 |
|
barnard |
|
US417671A
(en)
|
|
1889-12-17 |
|
Henry esbach |
|
US4184917A
(en)
|
1974-04-01 |
1980-01-22 |
Sandoz Ltd. |
Process for producing a structurally modified interferon
|
|
US4321365A
(en)
|
1977-10-19 |
1982-03-23 |
Research Corporation |
Oligonucleotides useful as adaptors in DNA cloning, adapted DNA molecules, and methods of preparing adaptors and adapted molecules
|
|
US4293652A
(en)
|
1979-05-25 |
1981-10-06 |
Cetus Corporation |
Method for synthesizing DNA sequentially
|
|
US4351901A
(en)
|
1980-03-24 |
1982-09-28 |
Cetus Corporation |
Method for single nucleotide alteration
|
|
US5036006A
(en)
|
1984-11-13 |
1991-07-30 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US4945050A
(en)
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US5100792A
(en)
|
1984-11-13 |
1992-03-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US5273876A
(en)
|
1987-06-26 |
1993-12-28 |
Syntro Corporation |
Recombinant human cytomegalovirus containing foreign gene
|
|
DE10399032I1
(de)
|
1987-08-28 |
2004-01-29 |
Health Research Inc |
Rekombinante Viren.
|
|
US5179022A
(en)
|
1988-02-29 |
1993-01-12 |
E. I. Du Pont De Nemours & Co. |
Biolistic apparatus for delivering substances into cells and tissues in a non-lethal manner
|
|
CA2045129A1
(en)
|
1989-02-01 |
1990-08-02 |
Alfred I. Geller |
Herpes simplex virus type i expression vector
|
|
GB8923123D0
(en)
|
1989-10-13 |
1989-11-29 |
Connaught Lab |
A vaccine for human immunodeficiency virus
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
EP0500799B1
(en)
|
1989-11-16 |
1998-01-14 |
Duke University |
Particle mediated transformation of animal skin tissue cells
|
|
FR2658432B1
(fr)
|
1990-02-22 |
1994-07-01 |
Medgenix Group Sa |
Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation.
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
MY109299A
(en)
|
1990-08-15 |
1996-12-31 |
Virogenetics Corp |
Recombinant pox virus encoding flaviviral structural proteins
|
|
EP0549723A1
(en)
|
1990-09-21 |
1993-07-07 |
Chiron Corporation |
Packaging cells
|
|
ATE188740T1
(de)
|
1991-02-19 |
2000-01-15 |
Univ California |
Viruspartikel mit veraendertem wirtspektrum
|
|
GB9105383D0
(en)
|
1991-03-14 |
1991-05-01 |
Immunology Ltd |
An immunotherapeutic for cervical cancer
|
|
US6013638A
(en)
|
1991-10-02 |
2000-01-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
|
|
AU3972893A
(en)
|
1992-04-03 |
1993-11-08 |
Baylor College Of Medicine |
Gene therapy using the intestine
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5831005A
(en)
|
1992-09-24 |
1998-11-03 |
Chiron Corporation |
Synthesis of N-substituted oligomers
|
|
AU6014094A
(en)
|
1992-12-02 |
1994-06-22 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
|
US5654186A
(en)
|
1993-02-26 |
1997-08-05 |
The Picower Institute For Medical Research |
Blood-borne mesenchymal cells
|
|
AU680508B2
(en)
|
1993-04-06 |
1997-07-31 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Gibbon ape leukemia virus-based retroviral vectors
|
|
US6133028A
(en)
|
1993-05-28 |
2000-10-17 |
Transgene S.A. |
Defective adenoviruses and corresponding complementation lines
|
|
US6140087A
(en)
|
1993-06-24 |
2000-10-31 |
Advec, Inc. |
Adenovirus vectors for gene therapy
|
|
US6120764A
(en)
|
1993-06-24 |
2000-09-19 |
Advec, Inc. |
Adenoviruses for control of gene expression
|
|
US5834441A
(en)
|
1993-09-13 |
1998-11-10 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Adeno-associated viral (AAV) liposomes and methods related thereto
|
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
|
AU7353494A
(en)
|
1993-11-12 |
1995-05-29 |
Case Western Reserve University |
Episomal expression vector for human gene therapy
|
|
WO1995019799A1
(en)
|
1994-01-21 |
1995-07-27 |
Agracetus, Inc. |
Gas driven gene delivery instrument
|
|
US5731172A
(en)
|
1994-03-09 |
1998-03-24 |
Sumitomo Pharmaceuticals Company, Ltd. |
Recombinant adenovirus and process for producing the same
|
|
US5833993A
(en)
|
1994-04-29 |
1998-11-10 |
Pharmacia & Upjohn Company |
Feline immunodeficiency virus vaccine
|
|
US5604090A
(en)
|
1994-06-06 |
1997-02-18 |
Fred Hutchinson Cancer Research Center |
Method for increasing transduction of cells by adeno-associated virus vectors
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US5693508A
(en)
|
1994-11-08 |
1997-12-02 |
Chang; Lung-Ji |
Retroviral expression vectors containing MoMLV/CMV-IE/HIV-TAR chimeric long terminal repeats
|
|
US5656611A
(en)
|
1994-11-18 |
1997-08-12 |
Supratek Pharma Inc. |
Polynucleotide compositions
|
|
WO1996017072A2
(en)
|
1994-11-30 |
1996-06-06 |
Chiron Viagene, Inc. |
Recombinant alphavirus vectors
|
|
AUPN015794A0
(en)
*
|
1994-12-20 |
1995-01-19 |
Csl Limited |
Variants of human papilloma virus antigens
|
|
GB9502879D0
(en)
|
1995-02-14 |
1995-04-05 |
Oxford Biosciences Ltd |
Particle delivery
|
|
JP3770333B2
(ja)
|
1995-03-15 |
2006-04-26 |
大日本住友製薬株式会社 |
組換えｄｎａウイルスおよびその製造方法
|
|
GB9506782D0
(en)
|
1995-04-01 |
1995-05-24 |
British Biotech Pharm |
Retroviral vectors
|
|
JPH11511326A
(ja)
|
1995-08-30 |
1999-10-05 |
ジエンザイム コーポレイション |
アデノウィルスおよびａａｖの精製
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
CA2247091A1
(en)
|
1996-03-05 |
1997-09-12 |
The Regents Of The University Of California |
Recombinant live feline immunodeficiency virus and proviral dna vaccines
|
|
US5952221A
(en)
|
1996-03-06 |
1999-09-14 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a first and second nucleic acid sequence
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
CN1247788C
(zh)
|
1997-05-13 |
2006-03-29 |
北卡罗来纳-查佩尔山大学 |
基于慢病毒的基因转移载体
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
WO2000000600A2
(en)
|
1997-09-22 |
2000-01-06 |
Chang Lung Ji |
Lentiviral vectors, comprising modified major donor splice sites and major packaging signals
|
|
ATE298371T1
(de)
|
1997-09-24 |
2005-07-15 |
Univ California |
Nicht-primaten lentivirale vektoren und verpackungssysteme
|
|
WO1999024465A1
(en)
|
1997-11-10 |
1999-05-20 |
Dana-Farber Cancer Institute |
Stabilized primate lentivirus envelope glycoproteins
|
|
JP2002508338A
(ja)
|
1997-12-12 |
2002-03-19 |
ナルディニ，ルイジ |
レンチウィルスベクターの治療使用
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
WO1999051754A1
(en)
|
1998-04-02 |
1999-10-14 |
Dana-Farber Cancer Institute, Inc. |
Infectious pseudotyped lentiviral vectors lacking matrix protein and uses thereof
|
|
DE60012711T2
(de)
|
1999-03-26 |
2005-08-18 |
Vical, Inc., San Diego |
Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe
|
|
CA2373300C
(en)
|
1999-04-14 |
2012-02-21 |
Chiron Corporation |
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
|
|
ATE368122T1
(de)
|
1999-04-29 |
2007-08-15 |
Cell Genesys Inc |
Verfahren und mittel für die herstellung von sicheren rekombinanten lentiviralen vektoren mit hohem titer
|
|
EP2100620A1
(en)
|
1999-09-16 |
2009-09-16 |
Eisai Corporation of North America |
Nucleic acids encoding polyepitope polypeptides
|
|
US6494865B1
(en)
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
|
WO2001081609A2
(en)
|
2000-03-22 |
2001-11-01 |
Chiron Corporation |
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
|
|
EP1278551A2
(en)
|
2000-04-21 |
2003-01-29 |
Vical Incorporated |
Compositions and methods for (in vivo) delivery of polynucleotide-based therapeutics
|
|
AU2002305914A1
(en)
|
2001-01-12 |
2002-10-21 |
Chiron Corporation |
Nucleic acid mucosal immunization
|
|
DE60126737T2
(de)
|
2001-03-23 |
2007-11-08 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Modifizierte HPV E6- und E7-Gene und -Proteine als Impfstoff
|
|
CA2448066A1
(en)
|
2001-05-31 |
2002-12-12 |
Chiron Corporation |
Chimeric alphavirus replicon particles
|
|
EP2801614B1
(en)
|
2002-08-29 |
2019-05-15 |
The Board of Trustees of the Leland Stanford Junior University |
Circular nucleic acid vectors and methods for making and using the same
|
|
US8137674B2
(en)
|
2006-04-19 |
2012-03-20 |
Postech Foundation |
Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer
|
|
WO2009049350A1
(en)
*
|
2007-10-15 |
2009-04-23 |
The University Of Queensland |
Expression system for modulating an immune response
|
|
US9050287B2
(en)
*
|
2009-01-23 |
2015-06-09 |
The Trustees Of The University Of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
|
WO2012020871A1
(ko)
|
2010-08-13 |
2012-02-16 |
주식회사 제넥신 |
사람 파필로마바이러스 변형체 및 면역 증강제를 포함하는 자궁경부암 예방 또는 치료용 조성물
|
|
KR101206514B1
(ko)
|
2012-08-10 |
2012-11-30 |
서석윤 |
완충성이 우수한 목발
|
|
CN103772508B
(zh)
|
2014-01-15 |
2017-05-10 |
深圳泰来生物医药有限公司 |
免疫增强的人乳头瘤病毒感染及相关疾病的治疗性疫苗
|
|
JP6724853B2
(ja)
|
2017-04-24 |
2020-07-15 |
アイシン精機株式会社 |
駐車支援装置
|